CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted
Drug / intervention
Atorvastatin 20 mg daily for 3 monthsdrug
Likely dose
Atorvastatin 20 mg daily for 3 monthsfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00130481
NCT00130481N/ACompleted
CompareCT.gov

Pediatric Atorvastatin in Diabetes Intervention Trial (PADIT)

University of Florida·interventional·Posted Aug 15, 2005·Updated Mar 7, 2012

In Brief

A clinical study evaluating Atorvastatin 20 mg daily for 3 months for Type 1 Diabetes Mellitus and Type 2 Diabetes Mellitus. Completed, across 1 site.

Detailed Summary

The purpose of this study is to determine if Atorvastatin can improve blood vessel stiffness and blood vessel function in children 10-18 years old with Type 1 and Type 2 diabetes. Subjects will receive atorvastatin 20mg or placebo daily for 3 months and will then switch therapies for the next 3 months. Hypothesis: Atorvastatin will improve blood vessel function by decreasing arterial stiffness and improving blood flow.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsType 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedAug 15, 2005
Enrollment StartApr 1, 2005
Primary CompletionApr 1, 2007
TodayJul 2, 2026
Enrollment to primary: 2 yearsPosted 20.9 years ago

Interventions

Atorvastatin 20 mg daily for 3 monthsdrug